Last month, the American Board of Internal Medicine (ABIM) Foundation released the second wave of its groundbreaking campaign to identify and reduce low-value care, that is, common tests and procedures that are frequently overused or misused.
This Issue Brief describes the case of a genetic condition for which genetic screening of family members is clearly useful, and just as clearly underused. It explores the barriers to the use of genetic screening and has implications for the future as genetic technologies become more complex and produce more uncertainty.
This Issue Brief summarizes three related studies that describe primary care physicians’ attitudes toward considering costs in their clinical decisions, and the effects of providing cost-effectiveness information on physicians’ recommendations.
PI: Seema Sonnad, PhD
Abstract: The goal of this project is to use Medicare data to determine use of and variations in use of percutaneous breast biopsies across hospitals during a three year period.
Abstract: The appropriate adoption (and disadoption) and diffusion of medical innovation is central to the practice of high quality, cost-effective medical care. The gap between knowledge and practice - that many “good” innovations simply do not diffuse far enough or fast enough - frequently is cited as a major problem facing U.S. health care.
Abstract: The technology adoption literature often does not focus on the potential role of physicians, despite the fact that almost all medical technologies involve physician use or prescription. As such, there is a gap in understanding the role of physician selection in the adoption and diffusion of technology in health care. How does the uncertainty discouraging adoption balance out against the incentive for technological preeminence encouraging it?
PI: Sean Nicholson, PhD